查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541265

2024-2032 年按產品、應用、最終用途和地區分類的氧氣治療市場報告

Oxygen Therapy Market Report by Product, Application, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2023年全球氧療市場規模達189IMARC Group美元。慢性阻塞性肺病、氣喘、間質性肺病和肺炎等呼吸系統疾病的盛行率不斷上升，家庭醫療保健的需求不斷成長，因為與住院治療相比，家庭醫療保健更具成本效益，以及全球人口老化的加劇是推動該市場的一些主要因素。

氧氣治療市場分析：

主要市場促進因素：氣喘、慢性阻塞性肺病、間質性肺病和肺炎等疾病正在增加，刺激了對氧氣治療的需求。這加上老年人口的增加，是刺激氧氣治療市場成長的關鍵因素之一。

主要市場趨勢：家庭醫療保健是呼吸系統疾病患者的新趨勢，因為它為患者提供了便利。住院費用昂貴，而家庭醫療保健有助於省錢，這使得它非常受歡迎。

地理趨勢：由於吸菸和環境污染導致呼吸道疾病盛行率上升，北美引領市場。然而，隨著亞太地區老年人口的不斷增加，該地區正在成為氧氣治療的新興市場。

競爭格局：氧氣治療產業的一些主要市場參與者包括 Allied Healthcare Products Inc.、Becton Dickinson and Company、DeVilbiss Healthcare LLC (Drive Medical Inc.)、Fisher & Paykel Healthcare Limited、通用電氣公司、Getinge AB、Hersill SL、 Invacare Corporation、Koninklijke Philips NV、Smiths Group plc、Tecno-Gaz SpA、Teleflex Incorporated 等。

挑戰與機會：雖然市場面臨一些挑戰，例如某些地區的醫療保健服務有限，但它也遇到了遠距醫療整合和遠端監控功能等技術進步的機會。

氧氣治療市場趨勢：

家庭醫療保健趨勢

IMARC 集團的報告顯示，2023 年全球家庭醫療保健市場規模將達到3,922 億美元。環境。這種傾向正在推動對居家氧氣治療選擇的需求。家庭醫療保健通常比住院護理更便宜，可以減少住院時間和相關費用。家庭醫療設備重量輕、使用簡單，並允許患者保持活動能力和自由度，使家庭氧氣治療更加可行和有吸引力。許多慢性呼吸系統疾病，包括慢性阻塞性肺病和肺纖維化，需要長期吸氧治療。家庭醫療保健可以對各種疾病進行持續、一致的管理，從而提高患者對治療和結果的依從性。

呼吸道疾病的盛行率不斷增加

根據世界衛生組織（WHO）網站2023年發表的文章，全球第三大死因是慢性阻塞性肺病（COPD），2019年造成323萬人死亡。常見，需要氧氣治療來控制這些疾病的症狀。由於呼吸系統疾病會產生有害影響，只有長期治療才能幫助患者治療這些疾病，因此氧氣治療對於維持血液中足夠的氧氣水平，同時控制慢性呼吸系統疾病非常有價值。

人口老化

老年人更容易患有慢性阻塞性肺病、肺氣腫和肺炎等呼吸道疾病，氧氣治療是治療這些疾病的唯一方法。老年人可能患有多種慢性疾病，如高血壓、心臟病、糖尿病，這些疾病會加重呼吸道疾病，刺激對氧氣治療的需求。老年人的免疫系統較弱，可能會吸引多種感染，進而導致嚴重的呼吸道疾病。國際貨幣基金組織（IMF）電子圖書館網站上發表的一篇文章顯示，到2050年，全球80歲及以上人口的比例預計將翻兩番，達到近5%。

氧療市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、應用和最終用途對市場進行了分類。

按產品分類：

氧源設備

氧氣瓶

制氧機

液態氧裝置

氣道通氣設備

氧氣輸送裝置

氧氣面罩

鼻插管

文丘里面罩

非循環呼吸面罩

袋閥口罩

持續性呼吸道正壓通氣面罩

其他

氧源設備佔據大部分市場佔有率

該報告根據產品提供了詳細的市場細分和分析。這包括氧源設備（氧氣瓶、氧氣濃縮器、液態氧設備和 PAP 設備）和氧氣輸送設備（氧氣面罩、鼻插管、文丘里面罩、非循環呼吸面罩、袋閥面罩、CPAP 面罩等）。報告稱，氧源設備是最大的細分市場。

氧源設備對於氧氣治療至關重要，因為它為患者提供所需的氧氣。如果沒有這些設備，就很難為有需要的患者提供氧氣，這使得它們成為市場的必需品。這些設備可用於多種環境，包括醫院、診所和家庭醫療保健設施。他們在許多醫療保健環境中的適應性和要求推動了他們的強勁需求。氧源設備的不斷進步和改進，例如攜帶式和輕型設計、更高的效率和方便用戶使用的功能，正在影響氧氣治療市場的概況。

按應用分類：

慢性阻塞性肺臟疾病

氣喘

阻塞性睡眠呼吸中止症

呼吸窘迫症候群

囊腫纖維化

肺炎

其他

慢性阻塞性肺病佔業界最大佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括慢性阻塞性肺病、氣喘、阻塞性睡眠呼吸中止症、呼吸窘迫症候群、囊性纖維化、肺炎等。報告稱，慢性阻塞性肺病佔據最大的市場佔有率。

COPD的高發生率直接對應於需要氧療的大量患者群體，使其成為最常見的應用領域。慢性阻塞性肺病是一種進行性慢性疾病，通常會隨著時間的推移而惡化，需要長期照護和治療。慢性阻塞性肺病患者可能需要持續或間歇性氧氣治療來控制症狀並維持生活品質。氧氣治療可緩解呼吸困難和嚴重呼吸短促，使其成為慢性阻塞性肺病管理的重要組成部分，從而對氧氣治療市場產生積極影響。

按最終用途細分：

家庭醫療保健

醫院

家庭醫療保健代表了領先的細分市場

該報告根據最終用途提供了詳細的市場細分和分析。這包括家庭醫療保健和醫院。根據該報告，家庭醫療保健是最大的細分市場。

患者喜歡在自己舒適的家中而不是在醫院或診所接受護理。家庭醫療保健使患者能夠繼續他們的習慣並留在熟悉的環境中，這可以提高他們的整體生活品質和護理滿意度。一般來說，家庭醫療保健的費用低於住院治療。無需長時間住院，降低醫療費用，減輕醫療機構的壓力。這種成本效益對患者和醫療保健專業人員都有吸引力。醫療技術的進步，特別是攜帶式製氧機和其他家用氧氣輸送系統的進步，簡化了患者在家中接受氧氣治療的過程。這些小工具變得更加方便用戶使用、高效和便攜，增加了它們對家庭使用的吸引力。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的氧氣治療市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是氧療最大的區域市場。

北美地區慢性阻塞性肺病、氣喘和睡眠呼吸中止症等呼吸系統疾病的盛行率很高，這些疾病是由人口老化、吸菸和環境污染等因素引起的。先進的醫療基礎設施、尖端醫療技術的廣泛應用以及可靠的醫療報銷法規都有助於推動市場向前發展。此外，家庭醫療保健的日益普及以及攜帶式和方便用戶使用的氧氣治療設備的出現使患者可以更輕鬆地在家中管理自己的疾病。此外，該地區的主要參與者正致力於擴大氧氣等氣體的儲存能力。例如，查特工業公司於 2024 年宣布其位於阿拉巴馬州西奧多的大型低溫儲槽製造工廠盛大開幕。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。氧療行業的一些主要市場參與者包括 Allied Healthcare Products Inc.、Becton Dickinson and Company、DeVilbiss Healthcare LLC (Drive Medical Inc.)、Fisher & Paykel Healthcare Limited、通用電氣公司、Getinge AB、Hersill SL、Invacare Corporation、 Koninklijke Philips NV、Smiths Group plc、Tecno-Gaz SpA、Teleflex Incorporated 等。

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

氧氣處理市場的主要公司積極參與各種策略活動，旨在擴大市場佔有率、改善產品供應並滿足不斷變化的客戶需求。氧療市場領導者正在投資研發 (R&D) 活動，以生產具有先進功能、改進便攜性和提高效率的革命性氧氣治療設備。此外，重要企業經常利用併購 (M&A) 和聯盟來擴大其產品組合、擴大其地理覆蓋範圍並進入新市場。例如，查特工業公司（Chart Industries, Inc.）是工業氣體、特種和能源轉型市場工藝技術和設備工程和製造領域的全球領導者，完成了對豪頓（Howden）的收購，豪頓是關鍵任務空氣和氣體處理產品的全球領先供應商，服務，由KPS Capital Partners, LP (“KPS”) 的附屬公司於2023 年提供。優勢的知識。

氧療市場新聞：

2023 年 7 月：艾默生推出了 ASCO™ 系列 588 固定式製氧機歧管，這是醫療保健行業首個交鑰匙歧管解決方案，旨在最佳化呼吸治療設備設計並加快產品上市速度。

本報告回答的關鍵問題

  • 全球氧氣治療市場有多大
  • 2024-2032年全球氧氣治療市場的預期成長率是多少
  • 推動全球氧氣治療市場的關鍵因素是什麼
  • COVID-19 對全球氧氣治療市場有何影響
  • 基於產品的全球氧氣治療市場的細分是什麼
  • 根據應用，全球氧氣治療市場的細分如何
  • 根據最終用途，全球氧氣治療市場的詳細情形如何
  • 全球氧氣治療市場的重點區域有哪些
  • 誰是全球氧氣治療市場的主要參與者/公司

本報告回答的關鍵問題

  • 全球氧氣治療市場有多大？ 2024-2032年全球氧氣治療市場的預期成長率是多少？
  • 推動全球氧氣治療市場的關鍵因素是什麼？
  • COVID-19 對全球氧氣治療市場有何影響？
  • 基於該產品的全球氧療市場的詳細情形如何？
  • 根據應用，全球氧氣治療市場的詳細情形如何？
  • 根據最終用途，全球氧氣治療市場的詳細情形如何？
  • 全球氧氣治療市場的重點區域有哪些？
  • 全球氧氣治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球氧氣治療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 氧源設備
    • 市場趨勢
    • 關鍵環節
      • 氧氣瓶
      • 制氧機
      • 液態氧裝置
      • 氣道通氣設備
    • 市場預測
  • 氧氣輸送裝置
    • 市場趨勢
    • 關鍵環節
      • 氧氣面罩
      • 鼻插管
      • 文丘里面罩
      • 非循環呼吸面罩
      • 袋閥口罩
      • 持續性呼吸道正壓通氣面罩
      • 其他
    • 市場預測

第 7 章：市場區隔：按應用

  • 慢性阻塞性肺臟疾病
    • 市場趨勢
    • 市場預測
  • 氣喘
    • 市場趨勢
    • 市場預測
  • 阻塞性睡眠呼吸中止症
    • 市場趨勢
    • 市場預測
  • 呼吸窘迫症候群
    • 市場趨勢
    • 市場預測
  • 囊腫纖維化
    • 市場趨勢
    • 市場預測
  • 肺炎
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：最終用途別

  • 家庭醫療保健
    • 市場趨勢
    • 市場預測
  • 醫院
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Allied Healthcare Products Inc.
    • Becton Dickinson and Company
    • DeVilbiss Healthcare LLC (Drive Medical Inc.)
    • Fisher & Paykel Healthcare Limited
    • General Electric Company
    • Getinge AB
    • Hersill SL
    • Invacare Corporation
    • Koninklijke Philips NV
    • Smiths Group plc
    • Tecno-Gaz SpA
    • Teleflex Incorporated
Product Code: SR112024A3847

The global oxygen therapy market size reached US$ 18.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032. The growing prevalence of respiratory diseases like COPD, asthma, interstitial lung disease, and pneumonia, rising need for home healthcare as it is more cost-effective compared to inpatient care, and increasing aging population worldwide are some of the major factors driving the market.

Oxygen Therapy Market Analysis:

Major Market Drivers: Diseases like asthma, COPD, interstitial lung disease, and pneumonia are increasing, which is catalyzing the demand for oxygen therapy. This, along with the rising geriatric population, represents one of the key factors stimulating the oxygen therapy market growth.

Key Market Trends: Home healthcare is the new trend among people suffering from respiratory diseases, as it provides convenience to patients. Hospitals stays are costly, and home healthcare helping in saving money, which makes it highly preferable.

Geographical Trends: North America leads the market because of rising prevalence of respiratory diseases owing to smoking and environmental pollution. However, as elderly population is increasing in the Asia Pacific region, this region is becoming an emerging market for oxygen therapy.

Competitive Landscape: Some of the major market players in the oxygen therapy industry include Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A.,Teleflex Incorporated, among many others.

Challenges and Opportunities: While the market faces challenges, such as limited healthcare access in several regions, it also encounters opportunities in technological advancements like telemedicine integration and remote monitoring capabilities.

Oxygen Therapy Market Trends:

Home Healthcare Trends

The IMARC Group's report shows that the global home healthcare market reached US$ 392.2 Billion in 2023. Many patients, particularly among the elderly and those with chronic diseases, prefer the comfort and convenience of receiving care at home over institutional settings, such as hospitals or nursing homes. This inclination is driving the demand for home oxygen therapy options. Home healthcare is frequently more affordable than inpatient care, lowering hospital stays and associated costs. Home healthcare devices are lightweight, simple to use, and allow patients to preserve their mobility and freedom, making home oxygen therapy more viable and appealing. Many chronic respiratory disorders, including COPD and pulmonary fibrosis, necessitate long-term oxygen treatment. Home healthcare allows for ongoing and consistent management of various illnesses, which improves patient adherence to treatment and outcomes.

Increasing Prevalence of Respiratory Diseases

According to an article published on the website of the World Health Organization (WHO) in 2023, the third leading cause of death worldwide is chronic obstructive pulmonary disease (COPD), causing 3.23 million deaths in 2019. COPD, asthma, interstitial lung disease, and pneumonia is very common and there is a requirement of oxygen therapy for managing the symptoms of these diseases. Because respiratory diseases have harmful impact and only long-term management can help patients treat these conditions, oxygen therapy is highly valuable in maintaining adequate levels of oxygen in the blood while managing chronic respiratory conditions.

Aging Population

Elderly people are more susceptible to respiratory conditions like COPD, emphysema, and pneumonia, and oxygen therapy is the only way to manage these conditions. Old people may have several chronic conditions, such as hypertension, heart disease, diabetes, which can worsen respiratory problems, thereby catalyzing the demand for oxygen therapy. The weak immune system of the geriatric population can attract several infections, which can lead to severe respiratory diseases. An article published on the website of the International Monetary Fund (IMF) eLibrary shows that by 2050 the global share of people aged 80 and older is expected to quadruple to almost 5%.

Oxygen Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end use.

Breakup by Product:

Oxygen Source Equipment

Oxygen Cylinders

Oxygen Concentrators

Liquid Oxygen Devices

PAP Devices

Oxygen Delivery Devices

Oxygen Masks

Nasal Cannula

Venturi Masks

Non-rebreather Masks

Bag Valve Masks

CPAP Masks

Others

Oxygen source equipment accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes oxygen source equipment (oxygen cylinders, oxygen concentrators, liquid oxygen devices, and PAP devices) and oxygen delivery devices (oxygen masks, nasal cannula, venturi masks, non-rebreather masks, bag valve masks, CPAP masks, and others). According to the report, oxygen source equipment represents the largest segment.

Oxygen source equipment is essential for oxygen treatment because it supplies patients with the oxygen they require. Without these devices, it would be hard to provide oxygen to patients in need, making them market essential. These devices are utilized in a variety of contexts, including hospitals, clinics, and home healthcare facilities. Their adaptability and requirement in many healthcare settings are driving their strong demand. Continuous advancements and improvements in oxygen source equipment, such as portable and lightweight designs, better efficiency, and user-friendly features, are influencing the oxygen therapy market overview.

Breakup by Application:

Chronic Obstructive Pulmonary Disease

Asthma

Obstructive Sleep Apnea

Respiratory Distress Syndrome

Cystic Fibrosis

Pneumonia

Others

Chronic obstructive pulmonary disease holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, pneumonia, and others. According to the report, chronic obstructive pulmonary disease accounts for the largest market share.

The high incidence of COPD directly corresponds to a large patient population requiring oxygen therapy, making it the most common application area. COPD is a progressive and chronic ailment that usually worsens with time, demanding long-term care and treatment. Patients with COPD may require continuous or intermittent oxygen therapy to control symptoms and maintain their quality of life. Oxygen treatment alleviates respiratory difficulties and severe shortness of breath, making it an essential part of COPD management, thereby positively influencing the oxygen therapy market insights.

Breakup by End Use:

Home Healthcare

Hospitals

Home healthcare represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end use. This includes home healthcare and hospitals. According to the report, home healthcare represents the largest segment.

Patients prefer to receive care in the comfort of their own homes rather than in hospitals or clinics. Home healthcare enables patients to continue their habits and remain in familiar settings, which can improve their overall quality of life and satisfaction with care. In general, home healthcare costs less than inpatient treatment. It eliminates the need for prolonged hospital stays, lowers healthcare expenses, and eases the pressure on healthcare institutions. This cost-effectiveness appeals to both patients and healthcare professionals. Medical technology advancements, particularly in portable oxygen concentrators and other home-use oxygen delivery systems, have simplified patients' access to oxygen therapy at home. These gadgets have become more user-friendly, efficient, and portable, increasing their attractiveness for home use.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest oxygen therapy market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for oxygen therapy.

North America has a high prevalence of respiratory disorders like COPD, asthma, and sleep apnea, which are caused by factors, such as aging populations, smoking, and environmental pollution. Advanced healthcare infrastructure, widespread availability of cutting-edge medical technologies, and solid healthcare reimbursement regulations all help to drive the market forward. Furthermore, the increasing popularity of home healthcare and the availability of portable and user-friendly oxygen therapy devices make it easier for patients to manage their diseases at home. Moreover, key players operating in this region are focusing on expanding their storage capacities of gases like oxygen. For instance, in 2024 Chart Industries announced the grand opening of its jumbo cryogenic tank manufacturing facility in Theodore, Alabama.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the oxygen therapy industry include Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A.,Teleflex Incorporated, etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key companies in the oxygen treatment market are actively involved in a variety of strategic activities aimed at increasing their market presence, improving product offerings, and fulfilling changing customer needs. Oxygen therapy market leaders are investing in research and development (R&D) activities to produce revolutionary oxygen therapy equipment with advanced features, improved portability, and increased efficiency. Furthermore, significant businesses frequently use mergers and acquisitions (M&A), and alliances to boost their product portfolios, expand their geographic reach, and enter new markets. For instance, Chart Industries, Inc., a global leader in engineering and manufacturing of process technology and equipment for industrial gas, specialty and energy transition markets, completed its acquisition of Howden, a leading global provider of mission critical air and gas handling products and services, from affiliates of KPS Capital Partners, LP ("KPS") in 2023. Some businesses are also engaging in marketing and educational initiatives to improve knowledge about respiratory health and the advantages of oxygen treatment.

Oxygen Therapy Market News:

July 2023: Emerson has launched the ASCO(TM) Series 588 Stationary Oxygen Concentrator Manifold, the healthcare industry's first turnkey manifold solution designed to optimize respiratory therapy device designs and accelerate product speed to market.

Key Questions Answered in This Report

  • 1. How big is the global oxygen therapy market?
  • 2. What is the expected growth rate of the global oxygen therapy market during 2024-2032?
  • 3. What are the key factors driving the global oxygen therapy market?
  • 4. What has been the impact of COVID-19 on the global oxygen therapy market?
  • 5. What is the breakup of the global oxygen therapy market based on the product?
  • 6. What is the breakup of the global oxygen therapy market based on the application?
  • 7. What is the breakup of the global oxygen therapy market based on the end use?
  • 8. What are the key regions in the global oxygen therapy market?
  • 9. Who are the key players/companies in the global oxygen therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oxygen Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oxygen Source Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Oxygen Cylinders
      • 6.1.2.2 Oxygen Concentrators
      • 6.1.2.3 Liquid Oxygen Devices
      • 6.1.2.4 PAP Devices
    • 6.1.3 Market Forecast
  • 6.2 Oxygen Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Oxygen Masks
      • 6.2.2.2 Nasal Cannula
      • 6.2.2.3 Venturi Masks
      • 6.2.2.4 Non-rebreather Masks
      • 6.2.2.5 Bag Valve Masks
      • 6.2.2.6 CPAP Masks
      • 6.2.2.7 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Chronic Obstructive Pulmonary Disease
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Obstructive Sleep Apnea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Respiratory Distress Syndrome
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cystic Fibrosis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pneumonia
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Home Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allied Healthcare Products Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fisher & Paykel Healthcare Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Getinge AB
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Hersill SL
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Invacare Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smiths Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tecno-Gaz S.p.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teleflex Incorporated
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oxygen Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Oxygen Therapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Oxygen Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Oxygen Therapy Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Oxygen Therapy Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Oxygen Therapy Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Oxygen Therapy Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Oxygen Therapy (Oxygen Source Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Oxygen Therapy (Oxygen Source Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Oxygen Therapy (Oxygen Delivery Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Oxygen Therapy (Oxygen Delivery Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Oxygen Therapy (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Oxygen Therapy (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Oxygen Therapy (Cystic Fibrosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Oxygen Therapy (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Oxygen Therapy (Pneumonia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Oxygen Therapy (Pneumonia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Oxygen Therapy (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Oxygen Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Oxygen Therapy (Home Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Oxygen Therapy (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Oxygen Therapy (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Oxygen Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Oxygen Therapy Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Oxygen Therapy Industry: SWOT Analysis
  • Figure 80: Global: Oxygen Therapy Industry: Value Chain Analysis
  • Figure 81: Global: Oxygen Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oxygen Therapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Oxygen Therapy Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Oxygen Therapy Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Oxygen Therapy Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Oxygen Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Oxygen Therapy Market: Competitive Structure
  • Table 7: Global: Oxygen Therapy Market: Key Players